Specification of Subject Sex in Oncology-Related Animal Studies
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Growing evidence for clinically significant differences between the sexes has attracted the attention of researchers. However, failures to report a test animal sex and balance the sex ratios of study samples remain widespread in preclinical investigations. We analyzed the sex-reporting rate and sex distributions of test animals in published oncology studies. Methods: We selected five oncology journals included in the Scientific Citation Index (SCI) based on impact factors. We identified preclinical investigations with in vivo mouse experiments published in 2015 for inclusion in our study sample. We classified each article by whether or not it reported test subject sex, and by which sex was included. We also recorded whether there were justifications for using one particular sex in single-sex studies (e.g., anatomical reasons) and whether sex-based analyses were conducted for both-sex studies. Results: We surveyed a total of 382 articles. Half (50.3%) failed to report test animal sex. Among articles that did report sex, 91.7% were single-sex studies, of which 69.4% did not provide any justifications for using the sex included in the study. Relatively few studies 15.7 studies included animals of both sexes, and only 2.3 studies conducted sex-based analyses. These findings are consistent with those of previous research that used other methods to collect data from the literature such as text mining, but our analysis of the provision of justifications for using one sex versus the other is a novel feature. Conclusions: Many researchers overlook test subject sex as a factor, but test animal sex should be reported in all preclinical investigations to enhance the reproducibility of research and avoid faulty conclusions drawn from one-sided studies.
Abstract
Background: Growing evidence for clinically significant differences between the sexes has attracted the attention of researchers. However, failures to report a test animal sex and balance the sex ratios of study samples remain widespread in preclinical investigations. We analyzed the sex-reporting rate and sex distributions of test animals in published oncology studies. Methods: We selected five oncology journals included in the Scientific Citation Index (SCI) based on impact factors. We identified preclinical investigations with in vivo mouse experiments published in 2015 for inclusion in our study sample. We classified each article by whether or not it reported test subject sex, and by which sex was included. We also recorded whether there were justifications for using one particular sex in single-sex studies (e.g., anatomical reasons) and whether sex-based analyses were conducted for both-sex studies. Results: We surveyed a total of 382 articles. Half (50.3%) failed to report test animal sex. Among articles that did report sex, 91.7% were single-sex studies, of which 69.4% did not provide any justifications for using the sex included in the study. Relatively few studies 15.7 studies included animals of both sexes, and only 2.3 studies conducted sex-based analyses. These findings are consistent with those of previous research that used other methods to collect data from the literature such as text mining, but our analysis of the provision of justifications for using one sex versus the other is a novel feature. Conclusions: Many researchers overlook test subject sex as a factor, but test animal sex should be reported in all preclinical investigations to enhance the reproducibility of research and avoid faulty conclusions drawn from one-sided studies.
참고문헌 (21)
- Franconi F, "Gender differences in drug responses", Pharmacol Res, 55, pp.81~95 (2007)[DOI]
- Hilliard LM, "Gender differences in pressure-natriuresis and renal autoregulation: role of the angiotensin type 2 receptor", Hypertension, 57, pp.275~282 (2011)[DOI]
- Wang X, "Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones", J Clin Endocrinol Metab, 96, pp.885~893 (2011)[DOI]
- Deasy BM, "A role for cell sex in stem cellmediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency", J Cell Biol, 177, pp.73~86 (2007)[DOI]
- Du L, "Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway", J Biol Chem, 279, pp.38563~38570 (2004)[DOI]
- Sorge RE, "Different immune cells mediate mechanical pain hypersensitivity in male and female mice", Nat Neurosci, 18, pp.1081~1083 (2015)[DOI]
- Sechzer JA, "Sex and gender bias in animal research and in clinical studies of cancer, cardiovascular disease, and depression", Ann N Y Acad Sci, 736, pp.21~48 (1994)[DOI]
- Huang RS, "Effect of population and gender on chemotherapeutic agentinduced cytotoxicity", Mol Cancer Ther, 6, pp.31~36 (2007)
- Midgley R, "Capecitabine: have we got the dose right?", Nat Clin Pract Oncol, 6, pp.17~24 (2009)
- Wang J, "Pharmacogenomics of sex difference in chemotherapeutic toxicity", Curr Drug Discov Technol, 4, pp.59~68 (2007)[DOI]
- Begley CG, "Drug development: raise standards for preclinical cancer research", Nature, 483, pp.531~533 (2012)[DOI]
- Beery AK, "Sex bias in neuroscience and biomedical research", Neurosci Biobehav Rev, 35, pp.565~572 (2011)[DOI]
- Mogil JS, "The case for the inclusion of female subjects in basic science studies of pain", Pain, 117, pp.1~5 (2005)[DOI]
- Schwartz S, "Feedback suppression of <TEX>$PI3K{\alpha}$<", TEX> signaling in PTEN-mutated tumors is relieved by selective inhibition of <TEX>$PI3K{\alpha}$<, Cancer Cell, pp.2015, 27[DOI]
- Langenkamp E, "Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival", Cancer Res, 75, pp.4504~4516 (2015)[DOI]
- Adams GN, "Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen", Cancer Res, 75, pp.4235~4243 (2015)[DOI]
- Wang SH, "Sorafenib action in hepatitis B virus X-activated oncogenic androgen pathway in liver through SHP-1", J Natl Cancer Inst, 107 (2015)
- Kim T, "Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis", J Natl Cancer Inst, 107 (2015)
- Kilkenny C, "Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research", PLoS Biol, 8, pp.e1000412~ (2010)[DOI]
- Florez-Vargas O, "Bias in the reporting of sex and age in biomedical research on mouse models", Elife, 5, pp.e13615~ (2016)
- McCullough LD, "NIH initiative to balance sex of animals in preclinical studies: generative questions to guide policy, implementation, and metrics", Biol Sex Differ, 5, pp.15~ (2014)[DOI]